A61K33/12

Correction of female urinary incontinence and skin reduction
10493295 · 2019-12-03 ·

The invention relates to devices and compositions useful for and methods of female genital skin reduction, improvement of skin tone and treatment of female urinary incontinence, as well as the treatment or improvement of other clinical conditions, including but not limited to those involving the female genitalia.

FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, FILAMENT FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, AND MATERIAL FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT

Provided is a fast-eluting three-dimensionally molded object, which is formed by fused deposition modeling type three-dimensional molding and quickly elutes an active component. The fast-eluting three-dimensionally molded object is formed by the fused deposition modeling type three-dimensional molding and includes an active component, a water-soluble thermoplastic polymer, a water-soluble sugar and/or a water-soluble sugar alcohol, and a plasticizer component. The fast-eluting three-dimensionally molded object has an elution rate of the active component of 80% or higher within 85 minutes by a dissolution test method in the Japanese Pharmacopoeia, Sixteenth Edition.

SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF
20240189228 · 2024-06-13 · ·

The present invention relates to a suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof.

SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF
20240189228 · 2024-06-13 · ·

The present invention relates to a suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof.

Veterinary Composition
20190151297 · 2019-05-23 · ·

The present invention relates to a veterinary composition for oral administration, said veterinary composition including an antacid and a therapeutically effective amount of a proton pump inhibitor, wherein the proton pump inhibitor is provided in an enteric coated form.

Veterinary Composition
20190151297 · 2019-05-23 · ·

The present invention relates to a veterinary composition for oral administration, said veterinary composition including an antacid and a therapeutically effective amount of a proton pump inhibitor, wherein the proton pump inhibitor is provided in an enteric coated form.

STABILIZED HYPOHALOUS ACID SOLUTIONS

The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solution, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing surfaces, or treating and/or preserving food products and cut flowers, among other uses.

STABILIZED HYPOHALOUS ACID SOLUTIONS

The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solution, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing surfaces, or treating and/or preserving food products and cut flowers, among other uses.

STABILIZED HYPOHALOUS ACID SOLUTIONS

The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solution, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing surfaces, or treating and/or preserving food products and cut flowers, among other uses.

Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof for use in the treatment of subpopulation of GERD patients
20190125665 · 2019-05-02 ·

The present invention relates to a chewable and/or suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof.